Kodiak Sciences Inc. financial data

Symbol
KOD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1200 Page Mill Rd, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Oligasis, LLC (to 7/28/2009)
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 889 % +55.8%
Debt-to-equity 95.2 % +29.1%
Return On Equity -89.1 % -11.1%
Return On Assets -45.6 % +1.15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.7M shares +0.41%
Common Stock, Shares, Outstanding 52.5M shares 0%
Entity Public Float 76.1M USD -65.8%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 52.6M shares +0.32%
Weighted Average Number of Shares Outstanding, Diluted 52.6M shares +0.32%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 126M USD -38.9%
General and Administrative Expense 60.8M USD -14.5%
Operating Income (Loss) -187M USD +32.6%
Net Income (Loss) Attributable to Parent -176M USD +32.4%
Earnings Per Share, Basic -3.35 USD/shares +32.6%
Earnings Per Share, Diluted -3.35 USD/shares +32.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 168M USD -41.1%
Marketable Securities, Current 0 USD -100%
Assets, Current 172M USD -40.6%
Property, Plant and Equipment, Net 102M USD -15.2%
Operating Lease, Right-of-Use Asset 46.5M USD -14.7%
Other Assets, Noncurrent 8.73M USD +0.14%
Assets 336M USD -30%
Accounts Payable, Current 3.92M USD -71.2%
Employee-related Liabilities, Current 5.27M USD -13.4%
Accrued Liabilities, Current 11M USD -39.9%
Liabilities, Current 25.6M USD -38.7%
Operating Lease, Liability, Noncurrent 59.7M USD -16.9%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 185M USD -13.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.33B USD -15.3%
Stockholders' Equity Attributable to Parent 150M USD -43.5%
Liabilities and Equity 336M USD -30%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.6M USD +16.1%
Net Cash Provided by (Used in) Financing Activities 38K USD
Net Cash Provided by (Used in) Investing Activities -166K USD -100%
Common Stock, Shares Authorized 490M shares 0%
Common Stock, Shares, Issued 52.7M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 247M USD -33.8%
Deferred Tax Assets, Gross 258M USD -33.2%
Operating Lease, Liability 70.3M USD -13.8%
Depreciation 4.7M USD +23.4%
Payments to Acquire Property, Plant, and Equipment 22K USD -99.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -176M USD +32%
Lessee, Operating Lease, Liability, to be Paid 88.6M USD -15.6%
Property, Plant and Equipment, Gross 143M USD +0.32%
Operating Lease, Liability, Current 10.6M USD +8.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.5M USD +1.34%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.9M USD +0.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.3M USD -21.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.81M USD -40.8%
Deferred Tax Assets, Operating Loss Carryforwards 147M USD +9.42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.8M USD +6.77%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.61M USD -12.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 10.3M USD -15.6%
Share-based Payment Arrangement, Expense 60.2M USD -32%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%